Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Once-daily raltegravir with unboosted atazanavir in adults with HIV-1 infection
2008-002695-94Phase 4Active
- Sponsor
- Fight AIDS and Infectious Diseases Foundation
- Start
- May 2008
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, single-arm trial of raltegravir and atazanavir in Human immunodeficiency virus infection type 1 and human immunodeficiency virus infection (HIV), sponsored by Fight AIDS and Infectious Diseases Foundation. Primary endpoints: Raltegravir AUC24h and Cmin and Proportion of patients with raltegravir Cmin below 33 nM. Started May 2008; status: active.
02
Drugs
raltegraviratazanavir
03
Conditions
Human immunodeficiency virus infection type 1human immunodeficiency virus infection (HIV)
Beyond the preview
Go deeper on 2008-002695-94.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2008-002695-94.